Julie A. Vetalice, Author at ORTHOWORLD

First DenerveX Cases in Germany

Medovex scheduled first cases in Germany for its DenerveX™ device to treat Facet Joint Syndrome.

Jul 25, 2017

Trauma and Spine Markets Gain New FDA Clearances

In 1H17, 23 orthopaedic companies from 11 countries received their first 510(k), according to FDA. We call your attention to these companies to assist you with identifying startups, as well as ex-U.S. companies entering the U.S. market.

Jul 21, 2017

DePuy Synthes 2Q17 Orthopaedic Revenue

Company Revenue The Numbers

ORTHOWORLD estimates DePuy Synthes’ 2Q17 orthopaedic revenue at US $2,214.8MM, +0.4% vs. 2Q16.

Jul 21, 2017

Tissue Regenix Proposes Acquisition of CellRight Technologies

Competitive Landscape Mergers & Acquisitions

Tissue Regenix proposes to acquire CellRight Technologies for US $30MM, to offer products for bone and soft tissue regeneration.

Jul 21, 2017

Paragon 28 Launches PROMO Triplanar Hallux Valgus Correction

ORTHOFLASH Trauma

Paragon 28 launched the Proximal Rotational Metatarsal Osteotomy Triplanar Hallux Valgus Correction system.

Jul 21, 2017

Premia Spine Launches IDE Study of TOPS Spinal Arthroplasty Device

ORTHOFLASH Spine

Premia Spine launched its U.S. pivotal Investigational Device Exemption study of the TOPS™ posterior arthroplasty device vs. traditional lumbar fusion.

Jul 20, 2017

Smith & Nephew, Imperial College to Study Meniscus Function

ORTHOFLASH Sports Medicine

Smith & Nephew signed a 3-year partnership with Imperial College London to study meniscus function and develop techniques to treat knee injuries caused by sports.

Jul 20, 2017